Experience

• • Five Arrows, the alternative assets arm of Rothschild & Co, and n2y in the merger of Texthelp with n2y.
  • Sawai and Sumitomo in the $210 million sale of its subsidiary Upsher-Smith Laboratories to Bora Pharmaceuticals.
  • Clayton, Dubilier & Rice in its acquisition of Shearer’s Foods, a leading contract manufacturer and private label supplier in the snack industry in North America.
  • Schneider Electric in the sale of its subsidiary AutoGrid, a Virtual Power Plant (VPP) and Distributed Energy Resource Management System (DERMS) provider, to Uplight.
  • Stepstone Group as lead investor in a $500 million single-asset continuation vehicle sponsored by WindRose Health Investors, a healthcare-focused private equity firm, to support the expansion of Healthmap Solutions, a population health management company focused on kidney disease.
  • Ascent, a global leading provider of expedited, time-critical logistics solutions and other transportation services, in its sale to affiliates of H.I.G.
  • TA Associates in its acquisition of PMA Financial Services from Estancia Capital Partners and PMA senior management.
  • Five Arrows, the alternative assets arm of Rothschild & Co., in its acquisition of a majority stake in n2y, a provider of comprehensive, SaaS-based solutions for students with unique learning challenges.
  • Morgan Stanley Capital Partners in its acquisition of Allstar Services and RowCal.
  • Mitsui in the formation of the Blue Water Alliance, a joint venture in partnership with Olin Corporation.
  • Pernod Ricard in its acquisition of a majority stake in Código 1530 Ultra Premium and Prestige Tequila.
  • EQT Exeter, a purpose-driven global investment organization, in its acquisition of Redwood Capital Group, an asset manager in the multifamily residential property space.
  • TA Associates, in its acquisition of TouchTunes, an in-venue, interactive music and entertainment platform, from funds advised by Searchlight and Newlight.
  • Carlyle, as majority owner of Syniverse, in the financing aspects of Syniverse’s $2.85 billion merger, later terminated, with special purpose acquisition company M3-Brigade Acquisition II Corp. resulting in Syniverse becoming a publicly traded company.
  • Clayton, Dubilier & Rice in the financing aspects of its $6 billion acquisition and subsequent combination of Fort Dearborn and Multi-Color Corporation, to create the world's largest label solutions company.
  • Clayton, Dubilier & Rice in the financing aspects of its $3.7 billion take-private acquisition of UDG Healthcare.
  • Precision Medical Group in its investment from funds managed by Blackstone.
  • Stone Point Capital in its investment in Lone Wolf Technologies, the North American leader in residential real estate software.
  • Aveva Group, a global leader in industrial software, in its $5 billion acquisition of OSIsoft.
  • Morgan Stanley Capital Partners and Pathway Vet Alliance in the $2.7 billion sale of a majority stake in Pathway to TSG Consumer Partners.
  • LeapFrog Investments in its investment in MedGenome, a leading genetic diagnostics, research and data company focused on expanding access for populations in South Asia and other emerging markets, with operations in the U.S., India, Canada and Singapore.